H. Richard Alexander
Surgical Metabolism Section
Surgery Branch
Division of Clinical Sciences
National Cancer Institute
USA
Name/email consistency: high
- Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases after irinotecan-based therapy. Alexander, H.R., Libutti, S.K., Pingpank, J.F., Bartlett, D.L., Helsabeck, C., Beresneva, T. Ann. Surg. Oncol. (2005)
- Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver. Alexander, H.R., Libutti, S.K., Pingpank, J.F., Steinberg, S.M., Bartlett, D.L., Helsabeck, C., Beresneva, T. Clin. Cancer Res. (2003)
- Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy. Alexander, H.R., Libutti, S.K., Bartlett, D.L., Pingpank, J.F., Kranda, K., Helsabeck, C., Beresnev, T. Cancer (2002)
- Augmented capillary leak during isolated hepatic perfusion (IHP) occurs via tumor necrosis factor-independent mechanisms. Alexander, H.R., Brown, C.K., Bartlett, D.L., Libutti, S.K., Figg, W.D., Raje, S., Turner, E. Clin. Cancer Res. (1998)
- Analysis of factors associated with long-term (five or more years) cure in patients undergoing operation for Zollinger-Ellison syndrome. Alexander, H.R., Bartlett, D.L., Venzon, D.J., Libutti, S.K., Doppman, J.L., Fraker, D.L., Norton, J.A., Gibril, F., Jensen, R.T. Surgery (1998)